Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

onepharm Research & Development GmbH

www.onepharm.com

Latest From onepharm Research & Development GmbH

Deals Shaping The Medical Industry, July-August 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

Savira Pharma, Roche licensing deal covers inhibition of influenza polymerase

The Austrian drug development company, Savira Pharmaceuticals, has granted Roche exclusive, worldwide rights to a small molecule programme where the goal is to use inhibition of the influenza polymerase as a promising target for novel anti-influenza drugs. Savira, founded in 2009, will receive an undisclosed upfront payment and research and development support, and is eligible for up to EUR240 million in milestones, plus royalties.

Infectious Diseases

Emergings in Brief

Start-Up showcases these recently launched companies: CFD Therapeutics, Heartscape Technologies, onepharm, Sorbent Therapeutics.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Dental & Oral Products
  • Gastrointestinal
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Austria
  • Parent & Subsidiaries
  • onepharm Research & Development GmbH
  • Senior Management
  • Bernhard Küenburg, PhD, CEO
  • Contact Info
  • onepharm Research & Development GmbH
    Phone: (43) 1-25077-5900
    Veterinärplatz 1
    Bldg. IA
    Vienna, 1210
    Austria
Advertisement
Advertisement
UsernamePublicRestriction

Register